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Abstract
Background: It is well established that adaptive immune responses induced by hypercholesterolemia play an
important role in the development of atherosclerosis, but the pathways involved remain to be fully characterized.
In the present study we assessed immune responses to hypercholesterolemia induced by feeding Apoe
-/- mice a
high-fat diet for 4 or 8 weeks.
Results: The primary immune response in lymph nodes draining the aortic root was an increased expression of
interferon (IFN)-g in CD8
+CD28
+ T cells, while an activation of IFN-g expression in CD4
+ T cells was observed only
after 8 weeks of high-fat diet. Contrarily, spleen CD4
+ T cells responded with a higher expression of IL-10. Spleen
CD8
+ T cells expressed both IFN-g and IL-10 and showed enhanced proliferation when exposed to Concanavalin A.
Plasma levels of IgG and IgM against oxidized LDL did not change, but the level of apolipoprotein B/IgM immune
complexes was increased.
Conclusion: Hypercholesterolemia leads to unopposed activation of Th1 immune responses in lymph nodes
draining atherosclerotic lesions, whereas Th1 activation in the spleen is balanced by a concomitant activation of
Th2 cells. The activation of CD8
+ T cells implies that hypercholesterolemia is associated with formation of cell
autoantigens.
Background
Both innate and adaptive immune responses contribute to
the arterial inflammation that characterizes atherosclerosis
[1-3]. Mice lacking critical components of innate immu-
nity, such as the Toll-like receptor (TLR) 2 and 4 and the
TLR signaling protein MyD88, develop less atherosclero-
sis, indicating the involvement of pro-atherogenic endo-
genous TLR ligands [4-6]. The role of adaptive immunity
in atherosclerosis is more complex. While there is strong
evidence that Th1 cells aggravate atherosclerosis [7-9] the
possible influence of Th2 cells is less clear [10,11]. Regula-
tory T cells (Tregs) [12,13] and B cells [14] appear to have
protective functions. A common feature of the studies that
have revealed these associations is that atherosclerosis has
been induced by hypercholesterolemia. Accordingly, it is
likely that the immune responses that contributed to
atherosclerosis development in these animals have been
activated by ligands and antigens generated by hypercho-
lesterolemia. The exact identity of these factors, as well as
their mode of action, remains to be fully characterized.
Attention has focused on the role of oxidized low-density
lipoprotein (LDL) [15]. LDL particles become oxidized by
various enzymes and oxygen metabolites when entrapped
in the extra cellular matrix of the artery wall [16].
Oxidized LDL is targeted by both IgM and IgG autoanti-
bodies [17] and as much as 10% of the T cells present in
atherosclerotic plaques are specific for antigens formed in
oxidized LDL [18]. T cells specific for oxidized LDL are
also present in the circulation [19] and transfer of CD4
+
T cells isolated from mice immunized with aldehyde-mod-
ified LDL results in a more aggressive development of
atherosclerosis [20] providing direct evidence for a patho-
genic role of adaptive immunity against modified LDL in
the disease process. Based on this knowledge attempts
have been made to develop immunomodulatory therapy
for prevention of cardiovascular disease and pilot vaccines
containing apolipoprotein B (apo B) antigens have
been shown to significantly reduce atherosclerosis in
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-/-) mice [21-23]. A limiting
factor in the development of these therapies has been the
poor understanding of the immune pathways activated by
hypercholesterolemia [24]. In the present studies we aimed
to address this issue by characterizing the induction of
adaptive immunity to hypercholesterolemia both systemi-
cally and in regional lymph nodes draining lesion-prone
areas of the aorta. We used Apoe
-/- mice in which a primary
immune response to hypercholesterolemia-associated anti-
gens, such as oxidized LDL, develops spontaneously [25].
To increase the antigen load we fed the mice a high-fat diet.
Methods
Animals
Female apolipoprotein E deficient mice on a C57BL/
6 background were purchased from Taconic, USA. The
animals were kept under controlled laboratory condi-
tions in individually ventilated cages and food and water
were provided ad libitum. All mice received chow diet
until the age of 10 weeks. One group (n = 27) was then
transferred to a high fat diet with 0.15% cholesterol and
21% fat (Lantmännen, Sweden) while the other group (n
= 24) remained on chow diet. Mice were killed 4 weeks
(high fat diet fed; n = 14, chow fed; n = 12) and 8 weeks
(high fat diet fed; n = 13, chow fed; n = 12) after diet
change, tissues were harvested and analyzed. The experi-
ments were approved by the Animal Care and Use
Committee of Lund University.
Analysis of plaque autoantibody, apolipoprotein B and
oxidized LDL content
The heart and proximal part of the aortic arch was
embedded in OCT (Tissue-Tek). Frozen sections of 10 μm
were collected from the subvalvular region. For detection
of IgG or IgM, slides were fixed in ice-cold acetone for
5 min and blocked with 10% mouse serum in PBS for
30 min. To detect IgM and IgG autoantibodies, slides
were incubated with biotinylated anti-mouse IgM or IgG
antibodies (Vector Laboratories) for 50 min at room tem-
perature. For the detection o fa p oBa n do x i d i z e dL D L ,
slides were fixed in ice-cold acetone for 5 min and blocked
with 10% goat serum in PBS for 50 minutes and incubated
overnight at 4°C with primary rabbit anti-mouse apo B
(Abcam) or anti-human malondialdehyde (MDA)-apo
B peptide (2D03, Bioinvent, Sweden) antibodies diluted in
10% goat serum in PBS. A biotinylated goat anti-rabbit
IgG antibody (Vector Laboratories) diluted in PBS was
used as secondary antibody. The reaction products were
visualized with Vectastain ABC elite kit (Vector Labora-
tories) using DAB as substrate (Vector Laboratories).
Slides were counter-stained with hematoxylin and omis-
sion of primary or secondary antibodies were used as con-
trols. Immune-stained areas were quantified with BioPix
iQ 2.0 software (Biopix, Sweden).
Cell preparation and flow cytometry
Mice were fasted for at least 3 hours before anesthetiza-
tion by intraperitoneal injection of Xylazine (Rompun,
Bayer Health care), and Ketamine (Ketalar, Pfizer) fol-
lowed by euthanization by heart puncture. The spleen,
mediastinal, brachial, axial, renal, iliac, sacral lymph
nodes and thymus were removed and meshed through a
cell strainer (70 μm, BD Bioscience). The single cell sus-
pension of the lymph nodes and thymus were washed in
RPMI medium (Gibco) and resuspended in complete
medium (RPMI 1640 supplemented with 10% FCS, 1%
Sodium pyruvate, 1% Hepes, 1% Penicillin/Streptomycin,
1% L-Glutamine and 0.1% b mercaptoethanol [Gibco]).
Splenocytes were pelleted and resuspended in red blood
cell lysing buffer (Sigma) for 2 minutes at room tem-
perature to remove erythrocytes. Cells were washed and
distributed in a 96 well round bottom plate (Sarstedt) at
a density of 2 × 10
6 cells/ml and incubated overnight in
a humidified chamber at 37°C and 5% CO2.D a y2 ,t h e
cells were incubated with 5 μg/ml brefeldin A
(eBioscience), 50 ng/ml PMA and 1 μg/ml ionomycin
(all from Sigma) for 4 hours. Cells were incubated with
a Fc-receptor blocking antibody (FcR;CD16/32; clone
93, Biolegend) for 5 minutes followed by incubation
with CD28-PE/Cy5 (clone 37.51), CD4-PE/Cy7 (GK1.5),
CD25-APC (PC61) and CD8-APC/Cy7 (53-6.7 all Biole-
gend) at 4°C for 30 minutes. The cells were resuspended
in Fix/Perm solution (eBioscience), washed with per-
meabilization buffer (eBioscience) and blocked with FcR
block prior to incubation with FoxP3-PB (clone FJK-16
S, eBioscience), IFN-g- FITC (clone XMG1.2, Biolegend),
IL-10-PE (clone JES5-16E3, Biolegend) for 30 minutes at
4°C. Cells were washed with permeabilization buffer and
resuspended in FC buffer (1% fetal calf serum [Gibco]
and 0.5 mM EDTA in phosphate buffered saline). Mea-
surements were performed using a Cyan ADP (Beckman
Coulter), analyses were performed using Summit (Beck-
man Coulter, version 4.3) and gating was adjusted using
a negative control staining.
Proliferation assay
Splenocytes (5 × 10
6) were centrifuged and resuspended
in 1 ml PBS. The cells were incubated with 10 μLC a r -
boxyfluorescerein Succinimidyl ester (CFSE; Invitrogen,
diluted 1:10 in PBS) for 5 minutes. The reaction was
stopped with addition of 1 ml FCS, cells were washed
with PBS and resuspended in 5 ml complete medium
(see above). Cells (1 × 10
6/ml) were transferred to a 96
well round bottom plate (Sarstedt) and incubated in pre-
sence or absence of 2.5 μg/ml Concanavalin A (ConA;
Sigma) for 4 days at 37°C and 5% CO2.C e l l sw e r e
stained with FcR block (CD16/32; Biolegend) prior to
staining with CD3-PE/Cy5 (clone 145-2C11), CD4-PE/
Cy7 and CD8a-APC/Cy7 (all Biolegend). Stained cells
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statistics were calculated on the number of CD4
+ and
CD8
+ cells that had proliferated more than one time.
Cells were acquired using a Cyan ADP (Beckman Coul-
ter) and analyses were performed using Summit (Beck-
man Coulter, version 4.3). For cytokine analysis 5 × 10
5
splenocytes were cultured alone or with 2.5 μg/ml Con
A for 72 hours and cytokine concentrations were mea-
sured in the cell culture supernatant using a Th1/Th2
9-plex (Meso Scale Discovery) according to the instruc-
tions of the manufacturer. The lower detection limit in
this assay was 5 pg/ml.
Plasma oxidized-LDL specific antibodies and
Apolipoprotein B immune complex analysis
Plasma oxidized-LDL-specific antibodies were analyzed in
Cu
2+ oxidized (10 μg/mL in PBS) or MDA-p210 peptide
(KTTKQ SFDLS VKAQY KKNKH; 10 μg/mL in PBS)
coated microtiter plates [26]. Plasma antibodies were
detected using antibodies recognizing mouse IgG, IgM
(Jackson ImmunoResearch), IgG1 (557272, BD Pharmin-
gen) and IgG2a (553389, BD Pharmingen; cross reacts with
IgG2c). In the apolipoprotein B immune complex assay,
microtiter plates were coated with rabbit anti-apolipopro-
tein B antibody (ABcam), and the plasma apo B containing
immune complexes were detected with the anti-mouse
IgG1 and IgG2a detection antibodies described above.
Analysis of cholesterol and triglyceride content
Total plasma cholesterol and plasma triglycerides were
quantified with colorimetric assays, Infinity™ Cholesterol
and Triglyceride (Thermo Electron).
Statistical analysis
Analysis of data was performed using unpaired t test or
Mann Whitney test for skewed data. Data are presented
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Figure 1 Plasma cholesterol and triglyceride levels in high fat diet (HFD) and chow diet fed mice. (A) Plasma concentration of cholesterol
in mice fed a high-fat diet (HFD) and mice fed a chow diet at 4 and 8 weeks of respective diet. (B) Plasma triglyceride concentration at week 4
and 8 weeks in HFD fed mice and chow fed mice. (C) Plasma HDL concentration at week 4 and 8 weeks in HFD fed mice and chow fed mice.
**P < 0.01, ***P < 0.001.
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Page 3 of 14as mean ± standard deviation. Analysis was performed
using GraphPad Prism 5.01 (Graphpad software) and a
level of P < 0.05 was considered significant.
Results
Effect of diet on plasma lipids and atherosclerosis
Apoe
-/- mice fed high fat diet had twice as high plasma
cholesterol levels as Apoe
-/- mice remaining on chow diet
at week 4 (493.6 ± 77.4 vs. 256.7 ± 50.7 mg/dl, P < 0.001,
Figure 1A) and week 8 (508.0 ± 98.0 vs. 270.9 ± 38.8 mg/
dl, P < 0.001, Figure 1A). Similarly, plasma HDL concen-
tration was higher in mice fed high fat diet (42.2 ± 20.6
v s .2 5 . 4±9 . 9m g / d l ,P <0 . 0 1a tw e e k4a n d3 9 . 5±1 8 . 3
v s .2 3 . 2±7 . 6m g / d la t ,P <0 . 0 1a tw e e k8 .F i g u r e1 C ) .
Triglyceride levels did not differ between the groups at 4
weeks (51.2 ± 9.8 (high fat diet) vs. 45.5 ± 5.5 (chow) mg/
dl, but were significantly lower in the high-fat group at 8
weeks (48.9 ± 8.9 vs. 60.9 ± 10.8 mg/dl, P <0 . 0 1 ,F i g u r e
1B). Four weeks of high fat diet generated a more than
two-fold increase in aortic root atherosclerotic plaque
area as compared with chow diet (1.6 ± 0.51 × 10
5 vs.
0.72 ± 0.47 × 10
5 μm
2 (P < 0.001, Figure 2). The plaque
area remained significantly increased in the high-fat
group after 8 weeks of diet (2.2 ± 0.93 × 10
5 vs. 1.3 ±
0.68 × 10
5 μm
2; P < 0.01, Figure 2) but the rate of pro-
gression between 4 and 8 weeks was approximately the
same in both groups. The fraction of the plaque demon-
strating positive immune-staining for oxidized LDL was
similar in both groups and for both time points (27.1 ±
12.3 vs. 23.1 ± 11.5% at 4 weeks and 30.9 ± 14.4 vs. 25.5
± 17.5% at 8 weeks, Figure 3). The same was true for apo
B immunoreactivity (21.8 ± 9.6 vs. 33.3 ± 15.6% at 4
weeks and 36.2 ± 15.3 vs. 35.4 ± 13.2% at 8 weeks, Figure
4). These findings suggest that the effect of a more severe
hypercholesterolemia on plaque growth was restricted to
the first 4 weeks of diet.
T cell activation
To determine if hypercholesterolemia and plaque
growth were associated with activation of adaptive
immunity we analyzed T cell activation in the spleen
and the mediastinal lymph nodes draining the aortic
root, as well as brachial, axial, renal, iliac, and sacral
lymph nodes, thymus and the circulation. The analysis
focused on IFN-g and IL-10 secreted by polyclonally
activated CD4
+ and CD8
+ T cells as depicted in Figure
5. We detected a diet-dependent immune response in
spleen and mediastinal lymph nodes but not in any of
the other tissues analyzed (data not shown) which
prompted us to focus the analysis on the two prior
tissues.
T cell activation in plaque draining lymph nodes
In spite of a markedly enhanced plaque formation there
was no evidence for increased activation of CD4
+ cells
in draining lymph nodes after 4 weeks of high-fat diet
(Figure 6A). The fraction of CD4
+ expressing IFN-g and
IL-10 was approximately equal. There was also no effect
on CD4
+CD25
+FoxP3
+ natural Tregs (8.1 ± 1.5% vs.
10.7 ± 8.2% of CD4
+ cells, non significant, n.s.), CD4
+CD28
+ IFN-g
+ T cells (12.6 ± 6.1% vs. 16.4 ± 6.5% of
CD4
+ cells, n.s.) or CD8
+ T cells (Figure 6B). However,
when the analysis was restricted to the CD28
+ popula-
tion of CD8
+ T cells an increased expression of IFN-g
Chow HFD Chow HFD
0
100000
200000
300000
400000
500000
***
**
Week 4 Week 8
Plaque area
A
r
e
a
 
(
m
m
2
)
Figure 2 Plaque area in aortic root. Quantification of plaque area in the aortic root of chow and high-fat diet (HFD) fed mice at 4 and 8
weeks. **P < 0.01, ***P < 0.001.
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Figure 3 Oxidized LDL deposition in the aortic root. Immunohistochemical staining and quantification of the fraction of oxidized LDL
(oxLDL) in aortic root sections from mice fed chow or high fat diet at 4 and 8 weeks respectively.
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Page 5 of 14was observed in the high-fat group (Figure 6C). There
was no difference in total mediastinal lymph node cell
numbers between the chow and high-fat groups at 4
weeks (Figure 7A).
At the 8 week time point clear signs of CD4
+ cell acti-
vation could be observed in the mediastinal lymph
nodes. The fraction of CD4
+ cells expressing IFN-g was
three-fold higher than the fraction of CD4
+ cells expres-
sing IL-10 and the CD4
+ expression of IFN-g was higher
in the high-fat group (Figure 6D). The expression of
IFN-g remained elevated in CD8
+CD28
+ T cells (Figure
6F), while no changes in the population of CD4
+CD25
+FoxP3
+ (8.6 ± 2.1% vs. 7.2 ± 1.6% of CD4
+ cells, n.s.),
CD4
+CD28
+ IFN-g
+ (31.7 ± 4.5% vs. 30.1 ± 4.3% of CD4
+ cells, n.s.) or CD8
+ T cells were detected (Figure 6E).
The total mediastinal lymph node cell numbers was
increased as compared to the 4 week time point, and
there was also a further increase in cell numbers in the
mice given high-fat diet (Figure 7A).
T cell activation in the spleen
Next we analyzed the systemic immune responses to
hypercholesterolemia. After 4 weeks of high-fat diet the
expression of IL-10 was increased in spleen CD4
+ cells,
whereas no effect on CD4
+IFN-g
+ (Figure 8A), CD4
+CD28
+ IFN-g expression (9.2 ± 3.5% vs. 11.3 ± 4.8% of
CD4
+ cells, n.s.) or CD4
+CD25
+FoxP3
+ (2.5 ± 0.8% vs.
3.4 ± 2.9% of CD4
+ cells, n.s.) populations were
observed. The expression of both IL-10 and IFN-g was
increased in spleen CD8
+ cells (Figure 8B) and the
expression of IFN-g was also increased in the CD8
+CD28
+ T cell population (Figure 8C). The proliferative
response to the polyclonal mitogen Concanavalin A
(ConA) was higher for CD8
+ cells than for CD4
+ cells
in both groups and high-fat diet resulted in a further
enhancement of the CD8
+ cell proliferative response
(Figure 9C).
At 8 weeks IL-10 expression remained elevated in
CD4
+ spleen cells from the high-fat group, but IFN-g
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Page 6 of 14was now more frequently expressed than IL-10 by CD4
+
cells in both groups (Figure 8D). We did not detect dif-
ferences in CD4
+CD25
+FoxP3
+ (2.3 ± 0.3% vs. 2.1 ±
0.6% of CD4
+ cells, n.s.) or CD4
+CD28
+ IFN-g
+ (27.7 ±
3.9% vs. 27.4 ± 4.1% of CD4
+ cells, n.s.). The CD8
+
expression of IFN-g was higher than at 4 weeks, but
there was no longer any difference between the groups
(Figure 8E and 8F). However, the proliferative response
of CD8
+ cells to ConA remained elevated in the high-fat
group (Figure 9D). In order to elucidate this discrepancy
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Figure 6 Expression of IFN-g and IL-10 in CD4
+ and CD8
+ cells in mediastinal lymph nodes (MeLN).F i g .A - Cd e p i c t sM e L Nc e l l sa t4
weeks and fig. D-F depicts MeLN cells at 8 weeks. There was no difference in IL-10 or IFN-g production in (A) CD4
+ or (B) CD8
+ cells between
mice fed a high fat diet (HFD) and a chow diet. (C) HFD-fed mice expressed a higher fraction of IFN-g producing CD8
+CD28
+ cells compared to
mice fed chow diet. (D) Increased IFN-g production of CD4
+ cells of high fat diet (HFD) fed mice compared to CD4
+ cells from mice fed a chow
diet. (E) No difference in the relative size of CD8
+IFN-g
+ and CD8
+IL-10
+ cells between mice fed HFD and chow diet. (F) Increased IFN-g
production in CD8
+CD28
+ cells in HFD-fed mice compared to mice fed chow diet. *P < 0.05, **P < 0.01.
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Figure 7 Total leukocyte counts. (A) There was no difference in MeLN total leukocyte number in mice receiving a high fat diet (HFD) compared
to mice fed a chow diet at 4 weeks of diet but increased leukocyte number at 8 weeks of HFD compared to chow diet. (B) There was no
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Figure 8 Expression of IFN-g and IL-10 in CD4
+ and CD8
+ cells in spleen. Fig. A-C depicts splenocytes at 4 weeks and fig. D-F depicts
splenocytes at 8 weeks. (A) Increased expression of IL-10 but not IFN-g in CD4
+ cells in high fat diet (HFD) fed mice compared to mice fed
chow diet. (B) Increased expression of IL-10 and IFN-g in CD8
+ and (C) IFN-g in CD8
+CD28
+ cells in HFD-fed mice compared to chow fed mice.
(D) Increased production of IL-10 in CD4
+ cells but not (E) CD8
+ cells and no difference in IFN-g production in (D) CD4
+, (E) CD8
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+CD28
+ cells in high fat diet (HFD) fed mice compared to mice fed chow diet. **P < 0.01, ***P < 0.001.
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+ T cell cytokine production and proliferation we
performed additional analyses studying the association
between activation of DNA synthesis, IL-10 and IFN-g
expression in spleen CD8 T cells isolated from mice
exposed to high-fat-diet. Interestingly, the results
demonstrated a strong association between DNA synth-
esis and IFN-g expression (r = 0.755, p = 0.005) along
with a strong inverse association between DNA synth-
esis and IL-10 expression (r = -0.72, p =0 . 0 0 8 ) .T h e s e
results suggest the induction of two distinct CD8 T cell
phenotypes, one proliferative and pro-inflammatory and
one quiescent and anti-inflammatory. To further asses
the effect of hypercholesterolemia on the balance
between Th1 and Th2 cells we analyzed the release of
IFN-g, IL-4 and IL-10 from cultured splenocytes
exposed to ConA. An increased capacity to express IL-4
was only observed in mice given a high-fat diet for 4
weeks (table 1), whereas no effects were seen on ConA-
induced IFN-g and IL-10 secretion at any time point.
Antibody levels in plasma and atherosclerotic lesions
To assess the effect of increased plasma cholesterol
levels on humoral immunity we determined plasma
levels of apo B/IgM and IgG immune complexes, as well
as autoantibodies against oxidized LDL and the oxidized
LDL antigen MDA-p210 (the 3136-3155 amino acid
sequence of apo B modified by malondialdehyde). High-
fat diet increased the level of plasma apo B/IgM
i m m u n ec o m p l e x e sa sc o m p a r e dt oc h o w( 0 . 3 6±0 . 3 3
vs. 0.17 ± 0.22 absorbance units at 4 weeks, p < 0.05
and 0.54 ± 0.40 vs. 0.12 ± 0.10 absorbance units at 8
weeks, p < 0.005, Figure 10A), whereas the level of apo
B/IgG immune complexes were low and did not differ
between the groups (Figure 10B). Plasma levels of IgM
against oxidized LDL and MDA-p210 as well as IgG
against MDA-p210 did not change in response to
increased hypercholesterolemia (Figure 11A-D) while
the IgM anti-oxLDL titer of mice fed high fat diet for 8
weeks was markedly increased compared to mice fed
chow diet for 4 weeks (Figure 11D). The IgG, IgG1 and
IgG2c antibody plasma concentration against oxLDL
was below detection limit (data not shown) and there
was also no effect on the MDA-p210 IgG1/IgG2a ratio
(data not shown). To determine if plaque size and
oxLDL accumulation affected the deposition of autoanti-
bodies we stained aortic root lesions for presence of
IgM and IgG antibodies. The fraction of IgM or IgG
antibodies was not different in plaques from high-fat
diet-fed Apoe
-/- mice compared to plaques from chow-
fed Apoe
-/- mice (Figures 12 and 13) at any time point.
Table 1 Cytokine production of stimulated splenocytes
IFN-g (pg/ml) IL-4 (pg/ml) IL-10 (pg/ml)
Chow HFD Chow HFD Chow HFD
4 weeks 620.8 ± 395.9 898.6 ± 784.3 8.5 ± 2.9 13.0 ± 3.4 83.3 ± 49.0 95.8 ± 80.0
P n.s ** n.s
8 weeks 1052.0 ± 803.8 574.6 ± 382.5 8.3 ± 2.8 8.8 ± 2.4 75.6 ± 28.9 82.7 ± 43.5
P n.s n.s n.s
Concentration of IL-4, IL-10 and IFN-g in cell supernatant of conA stimulated splenocytes from mice fed chow or high fat diet for 4 or 8 weeks. **P < 0.01.
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Figure 10 Antibody titer of anti-ApoB IgM/IgG immune complexes. Plasma antibody titer of (A) anti-ApoB IgM and (B) anti-ApoB IgG. *P <
0.05, ***P < 0.001.
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Page 9 of 14Since mice fed high fat diet develop larger plaques than
chow fed mice, this suggests a reciprocal relationship
between autoantibody deposition and plaque size.
Discussion
It is well established that adaptive immune responses
induced by hypercholesterolemia play an important role
in the development of atherosclerosis [2,3], but the path-
ways involved remain to be fully characterized. In
the present study we assessed the response of CD4
+ and
CD8
+ T cells, as well as humoral immunity, to a high-fat
diet. At 4 weeks the immune response to an aggravated
hypercholesterolemia was found to involve expression of
IFN-g by CD8
+CD28
+ T cells in plaque-draining lymph
nodes and in the spleen. At the latter location this pro-
inflammatory response was counterbalanced by a conco-
mitant release of IL-10 from both CD4
+ and CD8
+ T
cells, whereas no induction of IL-10 occurred in plaque-
draining lymph nodes. However, following an extended 8
weeks of high-fat diet activation of CD4
+ T cells could be
observed also in draining lymph nodes. As opposed to
the CD4
+ T cells in the spleen that remained in a
phenotype characterized by expression of IL-10, the med-
iastinal lymph node CD4
+ Tc e l l sb yt h e nh a dd i f f e r e n -
tiated into IFN-g secreting Th1 cells. Our findings imply
that when antigens generated in a hypercholesterolemic
state are acquired systemically and presented to T cells in
the spleen this results in differentiation of CD4
+ T cells
into IL-10 producing Th2 cells. This notion is in accor-
dance with previous studies by Zhou and coworkers
demonstrating that diet-induced hypercholesterolemia is
associated with a switch in oxidized LDL-specific IgG
towards a Th2 isotype [27]. Our observation of an
increased capacity of splenocytes from mice given high-
fat diet to secrete IL-4 is also in accordance with a
hypercholesterolemia-dependent shift towards Th2. In
contrast, when antigens generated by hypercholesterole-
mia are acquired in atherosclerotic lesions and presented
to T cells in draining lymph nodes this results in activa-
tion of Th1 cells. The reason why antigens generated by
hypercholesterolemia activates a Th2 response systemi-
cally but a Th1 immune response when acquired by anti-
gen presenting cells (APC) in atherosclerotic lesions
remains to be elucidated. One possibility could be that
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Figure 11 Antibody titer of anti-MDA-p210 IgM, IgG, IgG1 and IgG2c and anti-oxLDL IgM. Plasma antibody titer of anti-MDA-p210 IgG,
IgG1 and IgG2c at (A) 4 and (B) 8 weeks, (C) anti-MDA-p210 IgM and (D) anti-oxLDL IgM. **P < 0.01.
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Page 11 of 14the pro-inflammatory environment of the atherosclerotic
plaque activates APC to express co-stimulatory mole-
cules and cytokines in a manner that subsequently
primes naïve T cells in draining lymph nodes to Th1 dif-
ferentiation. Supporting this notion, dendritic cells pulsed
with oxLDL aggravate atherosclerosis or are atheropro-
tective depending on the priming environment. Habets et
al.u s e di n f u s e dD C sp u l s e dw ith copper-oxidized LDL
into LDLr
-/- hosts which reduced carotid lesion size and
increased plaque stability [28]. On the contrary, MDA-
LDL pulsed DCs aggravated atherosclerosis in Apoe
-/-
mice [29]. Interestingly, immunization with MDA-LDL
in complete Freunds adjuvant is atheroprotective [30],
indicating that ex vivo primed DCs generate a pro-
inflammatory response whereas in vivo primed DCs are
anti-inflammatory. Gautier et al.r e p o r t e dt h a tD C si n
Apoe
-/- and LDLr
-/- mice are Th1 and Th17 disposed,
while removal of DCs increase hypercholesterolemia,
further supporting the dual role of DCs in atherosclerosis
[31]. Since the capability of DCs to prime CD4
+ T cells is
equivalent in normo- and hypercholesterolemic mice
[32], DCs may initiate the Th1 priming associated with
aggravated atherosclerosis as well as the Th2 response
present in splenocytes of mice given high fat diet. It is
also possible that Th1 priming of CD4
+ T cells in the
mediastinal lymph node could be aided by the IFN-g
secreting CD8
+ CD28
+ T cells that develop in draining
lymph nodes prior to the occurrence of CD4
+ Th1 cells.
An unexpected finding in the present study was that the
initial pro-inflammatory response to hypercholesterolemia
was started by CD8
+ T cells and not by CD4
+ T cells. The
role of CD8
+ T cells in atherosclerosis has not been exten-
sively studied. CD8
+ T cells are present in atherosclerotic
lesions of Apoe
-/- mice, but are less frequent than CD4
+ T
cells [33]. However, in advanced human lesions the CD8
+
T cells may account for up to 50% of the entire leukocyte
population [34]. Targeting of a CD8
+ T cell immune
response against arterial smooth muscle cells has been
shown to markedly aggravate atherosclerosis in Apoe
-/-
mice [35]. CD8
+ T cells have also been implicated in the
accelerated atherosclerosis that occurs in patients with
autoimmune diseases such as systemic lupus erythemato-
sus [36]. In a study by Elhage and coworkers [37] CD8
deficiency did not influence atherosclerosis development
in Apoe
-/- mice. However, in the same study it was unex-
pectedly found that deficiency of CD4 increased plaque
formation. The authors concluded that this could be due
to the expansion of CD8
+ T cell population that charac-
terizes CD4
-/- mice.
Our findings do not permit any clear conclusion regard-
ing the antigen(s) responsible for hypercholesterolemia-
induced immune activation. It is generally assumed that
oxidized LDL is a dominant autoantigen generated by
hypercholesterolemia [38]. In agreement with previous stu-
dies oxidized LDL IgG and IgM autoantibodies were pre-
sent in chow-fed Apoe
-/- mice [25] and the levels did not
change significantly in response to high-fat diet. In con-
trast, mice fed a high-fat diet were found to have higher
levels of apo B/IgM immune complexes in the circulation
which could reflect an increase in the amount of circulat-
ing oxidized LDL as well as an enhanced generation of
anti-oxidized LDL IgM. There was however no change in
the anti-oxLDL IgG1/IgG2c ratio. This observation is in
contrast to studies by Zhou et al. [27] demonstrating a
shift towards Th2 isotype anti-oxidized LDL IgG in severe
hypercholesterolemia. The reason for this discrepancy
remains to be clarified but may involve the difference in
antigens used in the ELISAs. However, the observation
that high-fat diet increased the capacity of splenocytes to
secrete IL-4 suggests that hypercholesterolemia stimulated
a shift towards Th2 also in the present study. In order to
further develop the assay, it would be interesting to deter-
mine if the origin of IL-4 production is CD4
+ or CD8
+ T
cell specific. An important limitation that should be kept in
mind when interpreting the present findings is that mouse
models of atherosclerosis may not be entirely representa-
tive of the pathophysiology of human atherosclerosisis [39].
Moreover, it is also unlikely that the sudden increase in
plasma cholesterol levels observed in response to high fat
diet in the present study would occur in humans. Never-
theless, in spite of these limitations, our findings provide
support for a role of CD8
+ T cells in immune responses
activated by hypercholesterolemia.
The accumulation of oxidized LDL in atherosclerotic
lesions was correlated to lesion size. In spite of this
there were no signs of activation of CD4
+ T cells in
draining lymph nodes 4 weeks after diet change, sug-
gesting a lack of reactivity against extracellular antigens
such as oxidized LDL. The observation of increased
IFN-g expression in CD8
+CD28
+ T cells instead point to
an initial immune response against cell antigens.
Although immune responses against apoptotic cells gen-
erally are tolerogenic and inhibit atherosclerosis [40] it
can not be excluded that this represents an immune
response against damaged vascular cells.
Conclusions
In conclusion the present observations demonstrate that
hypercholesterolemia leads to activation of an unopposed
Th1 immune response in lymph nodes draining athero-
sclerotic plaques, whereas this response in the spleen is
balanced by a concomitant activation of IL-10 expressing
Th2 cells. They also show that CD8
+ T cells may have an
equally important role as CD4
+ T cells in hypercholester-
olemia-induced immune activation implicating genera-
tion of cellular autoantigens.
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